Details of the Drug

General Information of Drug (ID: DMAFUIR)

Drug Name
DWP-431
Synonyms Recombinant bone morphogenetic protein 2 (bone synthesis), Daewoong; RBMP-2 (bone synthesis), Daewoong
Indication
Disease Entry ICD 11 Status REF
Bone development disorder FB86 Phase 3 [1]
Cross-matching ID
TTD ID
D03HDV

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bone morphogenetic protein 2 (BMP2) TTP3IGX BMP2_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01634308) Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation. U.S. National Institutes of Health.
2 Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. Spine J. 2014 Mar 1;14(3):552-9.